{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T19:27:29Z","timestamp":1791055649225,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2002,7,1]],"date-time":"2002-07-01T00:00:00Z","timestamp":1025481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":4907,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2002,7]]},"DOI":"10.1046\/j.1523-1755.2002.00423.x","type":"journal-article","created":{"date-parts":[[2002,7,28]],"date-time":"2002-07-28T17:44:13Z","timestamp":1027878253000},"page":"301-310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":165,"title":["Advanced glycation end products and mortality in hemodialysis patients"],"prefix":"10.1016","volume":"62","author":[{"given":"Susanne B.","family":"Schwedler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Metzger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"Schinzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Wanner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1046\/j.1523-1755.2002.00423.x_bb0010","series-title":"Glycation and Advanced Glycation Endproducts","first-page":"59","article-title":"The glycation hypothesis,","author":"Westwood","year":"1997"},{"key":"10.1046\/j.1523-1755.2002.00423.x_bb0015","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev.med.46.1.223","article-title":"Advanced protein glycosylation in diabetes and aging","volume":"46","author":"Brownlee","year":"1995","journal-title":"Annu Rev Med"},{"key":"10.1046\/j.1523-1755.2002.00423.x_bb0020","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM199109193251202","article-title":"Advanced glycosylation end products in patients with diabetic nephropathy","volume":"325","author":"Makita","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1755.2002.00423.x_bb0025","first-page":"1081","article-title":"The pathogenesis and consequences of AGE formation in uraemia and its treatment","volume":"44","author":"Dawnay","year":"1998","journal-title":"Cell Mol Biol"},{"key":"10.1046\/j.1523-1755.2002.00423.x_bb0030","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1159\/000045934","article-title":"Advanced glycation endproducts in end-stage renal disease and their removal","volume":"87","author":"Schinzel","year":"2001","journal-title":"Nephron"},{"key":"10.1046\/j.1523-1755.2002.00423.x_bb0035","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1046\/j.1523-1755.1998.00756.x","article-title":"Renal catabolism of advanced glycation end products: The fate of pentosidine","volume":"53","author":"Miyata","year":"1998","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2002.00423.x_bb0040","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/BF00403957","article-title":"Renal fate of circulating advanced glycated end products (AGE): Evidence for reabsorption and catabolism of AGE-peptides by renal proximal tubular cells","volume":"39","author":"Gugliucci","year":"1996","journal-title":"Diabetologia"},{"key":"10.1046\/j.1523-1755.2002.00423.x_bb0045","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1046\/j.1523-1755.1999.00302.x","article-title":"Alterations in nonenzymatic biochemistry in uremia: Origin and significance of \u201ccarbonyl stress\u201d in long-term uremic complications","volume":"55","author":"Miyata","year":"1999","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2002.00423.x_bb0050","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0272-6386(00)70189-2","article-title":"Advanced glycation end products: A Nephrologist's perspective","volume":"35","author":"Raj","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2002.00423.x_bb0055","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0008-6363(97)00233-2","article-title":"AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept","volume":"37","author":"Bierhaus","year":"1998","journal-title":"Cardiovasc Res"},{"key":"10.1046\/j.1523-1755.2002.00423.x_bb0060","doi-asserted-by":"crossref","first-page":"9982","DOI":"10.1074\/jbc.271.17.9982","article-title":"The advanced glycation end product, Nepsilon-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions","volume":"271","author":"Fu","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1046\/j.1523-1755.2002.00423.x_bb0065","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/0306-3623(95)02054-3","article-title":"Pharmacology of methylglyoxal: Formation, modification of proteins and nucleic acids, and enzymatic detoxification\u2014A role in pathogenesis and antiproliferative chemotherapy","volume":"27","author":"Thornalley","year":"1996","journal-title":"Gen Pharmacol"},{"key":"10.1046\/j.1523-1755.2002.00423.x_bb0070","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1172\/JCI119180","article-title":"Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging","volume":"99","author":"Schleicher","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1523-1755.2002.00423.x_bb0075","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1161\/01.ATV.20.9.2094","article-title":"C-reactive protein in the arterial intima: Role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis","volume":"20","author":"Torzewski","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1046\/j.1523-1755.2002.00423.x_bb0080","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/bmj.321.7255.199","article-title":"Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses","volume":"321","author":"Danesh","year":"2000","journal-title":"BMJ"},{"key":"10.1046\/j.1523-1755.2002.00423.x_bb0085","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1046\/j.1523-1755.1999.00273.x","article-title":"Inflammation enhances cardiovascular risk and mortality in hemodialysis patients","volume":"55","author":"Zimmermann","year":"1999","journal-title":"Kidney Int"},{"issue":"Suppl 78","key":"10.1046\/j.1523-1755.2002.00423.x_bb0090","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1046\/j.1523-1755.2001.59780032.x","article-title":"Inflammation and advanced glycation end products in uremia: Simple coexistence, potentiation or causal relationship?","volume":"59","author":"Schwedler","year":"2001","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2002.00423.x_bb0095","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1053\/ajkd.2001.27695","article-title":"Serum Ne-(carboxymethyl)lysine levels in type 2 diabetic patients\u2014Impact on renal function","volume":"38","author":"Wagner","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2002.00423.x_bb0100","first-page":"669","article-title":"Determination of advanced glycation end products in serum by fluorescence spectroscopy and competitive ELISA","volume":"35","author":"M\u00fcnch","year":"1997","journal-title":"Eur J Clin Chem Clin Biochem"},{"key":"10.1046\/j.1523-1755.2002.00423.x_bb0105","first-page":"657","article-title":"Immunological determination of advanced glycosylation end-products in human blood and urine","volume":"10","author":"Dolhofer-Bliesener","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"10.1046\/j.1523-1755.2002.00423.x_bb0110","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/ki.1994.262","article-title":"Immunological quantification of advanced glycosylation end-products in the serum of patients on hemodialysis or CAPD","volume":"46","author":"Papanastasiou","year":"1994","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2002.00423.x_bb0115","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(94)92935-1","article-title":"Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure","volume":"343","author":"Makita","year":"1994","journal-title":"Lancet"},{"key":"10.1046\/j.1523-1755.2002.00423.x_bb0120","first-page":"153","article-title":"Chromatographic quantitation of plasma and erythrocyte pentosidine in diabetic and uremic subjects","volume":"41","author":"Odetti","year":"1992","journal-title":"Diabetes 1992"},{"key":"10.1046\/j.1523-1755.2002.00423.x_bb0125","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1046\/j.1523-1755.2000.00117.x","article-title":"Mechanisms for the formation of glycoxidation products in end-stage renal disease","volume":"57","author":"Weiss","year":"2000","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2002.00423.x_bb0130","doi-asserted-by":"crossref","first-page":"10872","DOI":"10.1021\/bi00034a021","article-title":"N epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins","volume":"34","author":"Reddy","year":"1995","journal-title":"Biochemistry"},{"key":"10.1046\/j.1523-1755.2002.00423.x_bb0135","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/0272-6386(95)90177-9","article-title":"Death risk predictors among peritoneal dialysis and hemodialysis patients: A preliminary comparison","volume":"26","author":"Lowrie","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2002.00423.x_bb0140","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/ki.1995.321","article-title":"Mechanisms of hypoalbuminemia in hemodialysis patients","volume":"48","author":"Kaysen","year":"1995","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2002.00423.x_bb0145","doi-asserted-by":"crossref","first-page":"6474","DOI":"10.1073\/pnas.94.12.6474","article-title":"Orally absorbed reactive glycation products (glycotoxins): An environmental risk factor in diabetic nephropathy","volume":"94","author":"Koschinsky","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1046\/j.1523-1755.2002.00423.x_bb0150","first-page":"1718","article-title":"The Maillard reaction\u2013from food chemistry to uraemia research","volume":"11","author":"Henle","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1046\/j.1523-1755.2002.00423.x_bb0155","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1046\/j.1523-1755.2000.00018.x","article-title":"Hyperhomocysteinemia, nutritional status, and cardiovascular disease in hemodialysis patients","volume":"57","author":"Suliman","year":"2000","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2002.00423.x_bb0160","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00041433-200002000-00003","article-title":"Endothelial dysfunctions: Common denominators in vascular disease","volume":"11","author":"De","year":"2000","journal-title":"Curr Opin Lipidol"},{"key":"10.1046\/j.1523-1755.2002.00423.x_bb0165","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1056\/NEJM200010193431609","article-title":"Inflammatory markers of coronary risk","volume":"343","author":"Rader","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1755.2002.00423.x_bb0170","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJM199704033361401","article-title":"Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men","volume":"336","author":"Ridker","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1755.2002.00423.x_bb0175","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0021-9150(99)00038-6","article-title":"N(epsilon)-(carboxymethyl)lysine in atherosclerotic vascular lesions as a marker for local oxidative stress","volume":"144","author":"Nerlich","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1046\/j.1523-1755.2002.00423.x_bb0180","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/BF03402128","article-title":"Detection of noncarboxymethyllysine and carboxymethyllysine advanced glycation end products (AGE) in serum of diabetic patients","volume":"5","author":"Takeuchi","year":"1999","journal-title":"Mol Med"},{"key":"10.1046\/j.1523-1755.2002.00423.x_bb0185","first-page":"293","article-title":"Pentosidine, carotid atherosclerosis and alterations in left ventricular geometry in hemodialysis patients","volume":"14","author":"Zoccali","year":"2001","journal-title":"J Nephrol"},{"key":"10.1046\/j.1523-1755.2002.00423.x_bb0190","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s001250051201","article-title":"Diabetic retinopathy risk correlates with intracellular concentrations of the glycoxidation product Nepsilon-(carboxymethyl) lysine independently of glycohaemoglobin concentrations","volume":"42","author":"Hammes","year":"1999","journal-title":"Diabetologia"},{"key":"10.1046\/j.1523-1755.2002.00423.x_bb0195","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1172\/JCI119885","article-title":"Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis","volume":"101","author":"Shinohara","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1523-1755.2002.00423.x_bb0200","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1172\/JCI118563","article-title":"BCL-2 expression or antioxidants prevent hyperglycemia-induced formation of intracellular advanced glycation endproducts in bovine endothelial cells","volume":"97","author":"Giardino","year":"1996","journal-title":"J Clin Invest"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815485503?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815485503?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T04:58:26Z","timestamp":1668574706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815485503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,7]]}},"alternative-id":["S0085253815485503"],"URL":"https:\/\/doi.org\/10.1046\/j.1523-1755.2002.00423.x","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2002,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advanced glycation end products and mortality in hemodialysis patients","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1046\/j.1523-1755.2002.00423.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2002 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}